1 / 48

Acute & Chronic Pancreatitis

Acute & Chronic Pancreatitis. Jasim Al- Abbad , MBBCh , FRCSC Assistant Professor General Surgery Colon and Rectal Surgery j asim.alabbad@hsc.edu.kw. inflammation of the gland parenchyma of the pancreas Acute vs. Chronic. Acute Pancreatitis. Introduction.

Download Presentation

Acute & Chronic Pancreatitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Acute & Chronic Pancreatitis Jasim Al-Abbad, MBBCh, FRCSC Assistant Professor General Surgery Colon and Rectal Surgery jasim.alabbad@hsc.edu.kw

  2. inflammation of the gland parenchyma of the pancreas • Acute vs. Chronic

  3. Acute Pancreatitis

  4. Introduction • The incidence of acute pancreatitis is increasing • > 300,000 hospital admissions annually in USA • 10 – 20 % of patients develop life-threatening form • Direct cost > 2 billion USD N Engl J Med 2006; 354:2142-2150 Gastroenterol Clin N Am 41 (2012) 1–8

  5. Mortality rate reach up to 30% with severe pancreatitis • Mortality is due to: • Multi-system organ failure (1st 2 weeks) • Septic complications (after 2 weeks) World J Gastroenterol 2007; 13:5043-5051

  6. Etiology • Gallstones • Alcohol • Hypertriglyceridemia • Hypercalcemia • Post ERCP • Trauma • Pancreatic duct obstruction • Infections • Drugs • Hereditary

  7. Gallstone Pancreatitis • The overall incidence in patients with symptomatic gallstones 3 – 8 % • Small gallstones are associated with an increased risk • 2 theories: • Obstructive • Pancreatic duct obstruction  excessive pressure  pancreatic injury • Reflux • Stone in ampulla of Vater bile reflux into pancreas  direct necrosis AdvSurg 2006; 40:265-284 N Engl J Med 2006; 354:2142-2150

  8. Pathophysiology

  9. Clinical Manifestations • Abdominal pain • Nausea / vomiting • Low grade fever • Dehydration • Epigastric tenderness • Jaundice • Grey Turner • Cullen's signs

  10. Diagnosis • History / physical examination • Biochemical workup • CBC • RFT • LFT • Amylase, lipase • Imaging

  11. Serum amylase • It rises within 6 to 12 hours of onset • Remains elevated for three to five days • There is no correlation between the magnitude of serum amylase elevation and severity of pancreatitis

  12. Causes of hyper-amylasemia: • Acute cholecystitis • Bowel obstruction • Mesenteric ischemia • Trauma • Ketoacidosis • Ruptured ectopic pregnancy • Parotitis • Renal failure • Salpingitis • Cirrhosis

  13. Serum lipase • More specific than amylase • Longer half life

  14. The elevation of ALT levels in the serum in the context of acute pancreatitis has a positive predictive value of 95% in the diagnosis of acute biliary pancreatitis AdvSurg 2006; 40:265-284

  15. Imaging • Plain x-rays • Ultrasound • CT scan • MRCP • ERCP • EUS

  16. Assessment of Severity of Disease • Early recognition of severe disease is crucial to optimize care and improve outcome • Many scoring systems developed

  17. Ranson’s criteria • Developed in 1974 • Score based on 11 parameters • Mortality • 0 to 3 % when the score <3 • 11 to 15 % when the score ≥3 • 40 % when the score ≥6

  18. It needs 48hrs to calculate • Meta-analysis of 110 clinical studies found Ranson's score to have a poor predictive power Crit Care Med. 1999;27(10):2272

  19. APACHE II score • 12 physiologic measurements • It provides a general measure of the severity of disease • A score of ≥8 defines severe pancreatitis

  20. CT severity index • Balthazar score • Based on CT findings

  21. Mortality 0-3 = 3% 4-6 = 6% 7-10= 17% Radiology 1990; 174:331

  22. C-Reactive Protein • Acute phase reactants made by the liver • Levels correlates with disease activity • Level ≥ 150 mg/mL defines severe pancreatitis Br J Surg. 1989;76(2):177

  23. Atlanta's Criteria for Acute Pancreatitis • The International Symposium on Acute Pancreatitis (1992) • Severe pancreatitis is defined by the presence of any evidence of organ failure or a local complication. Arch Surg1993; 128:586-590

  24. Treatment • Regardless of the cause or the severity of the disease • Aggressive fluid resuscitation • Pain control

  25. Nutritional support • Oral feeding may not be possible • Enteral feeding vs. TPN

  26. Prophylactic antibiotics • Data controversial • No benefit for pancreatitis without necrosis • Imipenemreduces pancreatic infections with proven necrosis Cochrane Database Syst Rev. 2010

  27. ERCP • Routine use of ERCP is not indicated • ERCP is indicated for: • Cholangitis • Persistent bile duct obstruction (obstructive jaundice)

  28. Laparoscopic Cholecystectomy • 30% of patients with acute biliary pancreatitis will have recurrent disease, in the absence of definitive treatment • For mild pancreatitis: • Early laparoscopic cholecystectomy (during the initial admission) is a safe procedure that decreases recurrence of the disease • For severe pancreatitis: • Early surgery may increase the morbidity and length of stay • Laparoscopic cholecystectomy should be delayed for at least 6 weeks AdvSurg 2006; 40:265-284

  29. Complications

  30. Acute Fluid Collections • Occur during the early stages of severe pancreatitis in 30% to 50% of patients • No wall of granulation or fibrous tissue, and more than half regress spontaneously. Pancreatic Necrosis • Areas of nonviable pancreatic tissue • either sterile or infected Pancreatic Pseudocyst • collections of pancreatic fluid enclosed by a non-epithelialized wall composed of fibrous and granulation tissue • Not present before 4 to 6 weeks after the onset of an attack Pancreatic Abscess • Collections of pus, usually in proximity to the pancreas

  31. Sabiston, David C., and Courtney M. Townsend. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. Philadelphia: Saunders/Elsevier, 2008. Print.

  32. Chronic Pancreatitis

  33. Persistent inflammation • Irreversible fibrosis • Atrophy of the pancreatic parenchyma • Chronic pain • Endocrine and exocrine insufficiency

  34. Brunicardi, F. Charles., and Seymour I. Schwartz. Schwartz's Principles of Surgery. New York: McGraw-Hill, Health Pub. Division, 2010. Print.

  35. Brunicardi, F. Charles., and Seymour I. Schwartz. Schwartz's Principles of Surgery. New York: McGraw-Hill, Health Pub. Division, 2010. Print.

  36. Etiology • Alcohol (70 - 80%) • Genetics (hereditary, CF gene mutation) • Hyperparathyroidisim • Hypertriglyceridemia • Autoimmune pancreatitis • Ductal obstruction (trauma, stones, tumors, ?pancreas divisum) • Smoking • Idiopathic

  37. Clinical Manifestations • Abdominal Pain • Pancreatic insufficiency • Fat malabsorption • Apancreatic diabetes

  38. Diagnosis • Blood tests: • CBC • RFT • LFT • Serum amylase and lipase levels usually normal • Functional tests • Fecal fat content • Fecal elastase-1 level

  39. Imaging: • CT scan • MRCP • EUS • ERCP

  40. Sabiston, David C., and Courtney M. Townsend. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. Philadelphia: Saunders/Elsevier, 2008. Print.

  41. Treatment Medical Treatment • Multidisciplinary team • Stop drinking and smoking • Pain control • Pancreatic enzyme replacement

  42. Endoscopic Treatment • ERCP with duct dilatation ± stent Surgical Treatment • Resection procedures • Drainage procedures

  43. Souba, Wiley W. ACS Surgery: Principles and Practice. Hamilton, Ont.: B C Decker, 2007. Print.

  44. Complications • Biliary strictures (jaundice / cholangitis) • Duodenal obstruction • Splenic / portal vein thrombosis • Pseudocyst

  45. Prognosis Brunicardi, F. Charles., and Seymour I. Schwartz. Schwartz's Principles of Surgery. New York: McGraw-Hill, Health Pub. Division, 2010. Print.

More Related